Byoung Chul Cho, MD, PhD

Articles by Byoung Chul Cho, MD, PhD

Enhanced Prophylactic Regimen Reduces Skin AEs With Amivantamab-Lazertinib: Byoung Chul Cho, MD, PhD

September 9th 2025

Byoung Chul Cho, MD, PhD, of the Yonsei University College of Medicine, discussed outcomes in the COCOON trial of an enhanced dermatologic regimen with amivantamab-lazertinib treatment.

Latest Updated Articles

Trending on AJMC

White House, Pfizer Reach Agreement on Drug Discounts; Trump Announces TrumpRx

Predicting Patient Response in the Move Toward Precision Medicine in Myasthenia Gravis

FDA Approves Remibrutinib for Chronic Spontaneous Urticaria

AI Seen as Key to Reducing Health Care Claim Denials, Survey Finds

Striking the Balance Between Cutting-Edge Oncology Care, Affordability: Brian Mulherin, MD